Anifrolumab, an Anti-Interferon-α Receptor Monoclonal Antibody, in Moderate-to-Severe Systemic Lupus Erythematosus
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Anifrolumab, an Anti-Interferon-α Receptor Monoclonal Antibody, in Moderate-to-Severe Systemic Lupus Erythematosus
Authors
Keywords
-
Journal
Arthritis & Rheumatology
Volume 69, Issue 2, Pages 376-386
Publisher
Wiley
Online
2016-11-08
DOI
10.1002/art.39962
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Sifalimumab, an anti-interferon-α monoclonal antibody, in moderate to severe systemic lupus erythematosus: a randomised, double-blind, placebo-controlled study
- (2016) Munther Khamashta et al. ANNALS OF THE RHEUMATIC DISEASES
- A Phase II study of the efficacy and safety of rontalizumab (rhuMAb interferon-α) in patients with systemic lupus erythematosus (ROSE)
- (2015) Kenneth C Kalunian et al. ANNALS OF THE RHEUMATIC DISEASES
- Targeting Interferons in Systemic Lupus Erythematosus: Current and Future Prospects
- (2015) Alexis Mathian et al. DRUGS
- Molecular basis for antagonistic activity of anifrolumab, an anti-interferon–α receptor 1 antibody
- (2015) Li Peng et al. mAbs
- Targeting of type I interferon in systemic autoimmune diseases
- (2015) Mary K. Crow et al. Translational Research
- A phase 2, randomised, placebo-controlled clinical trial of blisibimod, an inhibitor of B cell activating factor, in patients with moderate-to-severe systemic lupus erythematosus, the PEARL-SC study
- (2014) R A Furie et al. ANNALS OF THE RHEUMATIC DISEASES
- Advances in understanding the role of type I interferons in systemic lupus erythematosus
- (2014) Mary K. Crow CURRENT OPINION IN RHEUMATOLOGY
- Type I Interferon in the Pathogenesis of Lupus
- (2014) M. K. Crow JOURNAL OF IMMUNOLOGY
- Dose-escalation of human anti-interferon-α receptor monoclonal antibody MEDI-546 in subjects with systemic sclerosis: a phase 1, multicenter, open label study
- (2014) Avram Goldberg et al. ARTHRITIS RESEARCH & THERAPY
- Efficacy and safety of epratuzumab in patients with moderate/severe active systemic lupus erythematosus: results from EMBLEM, a phase IIb, randomised, double-blind, placebo-controlled, multicentre study
- (2013) Daniel J Wallace et al. ANNALS OF THE RHEUMATIC DISEASES
- Pharmacogenomics and Translational Simulations to Bridge Indications for an Anti-Interferon-α Receptor Antibody
- (2013) B Wang et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Type I interferon blockade in systemic lupus erythematosus: where do we stand?
- (2013) B. R. Lauwerys et al. RHEUMATOLOGY
- Overall and Cause-Specific Mortality in Patients With Systemic Lupus Erythematosus: A Meta-Analysis of Observational Studies
- (2013) Marko Yurkovich et al. ARTHRITIS CARE & RESEARCH
- The economic burden of systemic lupus erythematosus
- (2012) Pantelis Panopalis et al. BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY
- Emerging therapies for systemic lupus erythematosus — Focus on targeting interferon-alpha
- (2012) Eben I. Lichtman et al. CLINICAL IMMUNOLOGY
- Glucocorticoid use and abuse in SLE
- (2012) G. Ruiz-Irastorza et al. RHEUMATOLOGY
- Use of type I interferon-inducible mRNAs as pharmacodynamic markers and potential diagnostic markers in trials with sifalimumab, an anti-IFNα antibody, in systemic lupus erythematosus
- (2012) Yihong Yao et al. ARTHRITIS RESEARCH & THERAPY
- Development of the CLASI as a Tool to Measure Disease Severity and Responsiveness to Therapy in Cutaneous Lupus Erythematosus
- (2011) Rachel Klein et al. ARCHIVES OF DERMATOLOGY
- The type I interferon system in the development of lupus
- (2011) Lars Rönnblom et al. SEMINARS IN IMMUNOLOGY
- Numerical scoring for the BILAG-2004 index
- (2010) Chee-Seng Yee et al. RHEUMATOLOGY
- Building a Measure of Fatigue: The Functional Assessment of Chronic Illness Therapy Fatigue Scale
- (2010) Eleanor Smith et al. PM&R
- Novel evidence-based systemic lupus erythematosus responder index
- (2009) Richard A. Furie et al. ARTHRITIS AND RHEUMATISM
- Lupus: improving long-term prognosis
- (2008) A Doria et al. LUPUS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now